The influence of cardiac drugs on gingival enlargement
| Date Issued |
|---|
2012-09-07 |
Objectives: The purpose of the present study was to determine the prevalence and risk of gingival enlargement in patients using cardiac drugs. Material and methods: 80 patients (51 males and 29 females; average age 62,9 years, range 21 to 89) treated with cardiac drugs for mare than threee months were included in the study. All patients were examined for the presence of gingival enlargement using the vertical gingival overgrowth (GO) index. Presence of gingival inflammation, oral hygiene index and probing depth were also evaluated. The connection between nine most commonly used cardiac medications and gingival overgrowth was estimated. Statistical analysis was carried out using SPSS v.16. Results: Gingival enlargement occurred in 25% of the patients. 100% of them had grade 1 and 30% had grade 2 GO. The frequency of cardiac drugs usage was: Prestarium (8.8%), Aspirin (16.3%), Cardace (6.3%), Preductal (17.5%), Varfarin (8.8%), Moxonidin (7.5%), Nebilet (16,3%), Imdur (6.3%), Betaloc-zok (30%). [...].